Sort
17,288 grants matching “multiple sclerosis”
UTE MRI: A NOVEL BIOMARKER FOR REMYELINATION IN MULTIPLE SCLEROSIS PATIENTS
$969,000Regents Of The University Of California, San Francisco, The · · FY2021 · Defense Health Agency
Gene Regulation as a Foundation for Autoimmune Disease Prevention
$968,284Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · U01 · FY2020 · AI
CIRCULATING CNS CELL-DERIVED EXTRACELLULAR VESICLE BASED BIOMARKERS TO IDENTIFY NEURODEGENERATION AND GLIAL ACTIVATION IN MULTIPLE SCLEROSIS
$966,758The Johns Hopkins University · · FY2022 · Defense Health Agency
Gene Regulation as a Foundation for Autoimmune Disease Prevention
$963,738Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · AI
Safe and effective anti CD154 antibodies for therapeutic intervention
$962,696Matthew F. Mackey · Immunext, Inc. · R44 · FY2014 · AI
INTRANASAL INSULIN FOR IMPROVING COGNITIVE FUNCTION IN MULTIPLE SCLEROSIS
$961,578The Johns Hopkins University · · FY2016 · Department of the Army
The Role of Rare Variants in Multiple Sclerosis Risk
$961,201David A. Hafler · Yale University · RC2 · FY2009 · NS
Evaluation of clinical samples for virus detection for mechanism of CNS disease
$958,863Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome
$957,638Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
THE METABOLOMICS-NEUROFILAMENTS-NEURODEGENERATION NEXUS IN MULTIPLE SCLEROSIS PROGRESSION. NEW AWARD.
$957,000The Research Foundation For The State University Of New York · · FY2020 · Defense Health Agency
The Role of Rare Variants in Multiple Sclerosis Risk
$956,785David A. Hafler · Yale University · RC2 · FY2010 · NS
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$956,644Gary Fanger · Rise Therapeutics, Llc · R44 · FY2019 · DE
Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder
$956,407Parag Gad · Spinex, Inc. · R44 · FY2021 · DK
OVERCOMING HUMAN-SPECIFIC OBSTACLES TO SUCCESSFUL REMYELINATION IN MULTIPLE SCLEROSIS
$956,071The Research Foundation For The State University Of New York · · FY2021 · Defense Health Agency
A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
$956,049Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2024 · AI
IEDB for Multiple sclerosis, Rheumatoid Arthritis, Lupus, and Type 1 Diabetes
$955,828Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2013 · AI
A PILOT TRIAL OF REMOTELY SUPERVISED TRANSCRANIAL DIRECT CURRENT STIMULATION (RS-TDCS) TO ENHANCE MOTOR LEARNING IN PROGRESSIVE MULTIPLE SCLEROSIS (M
$954,572New York University · · FY2017 · Department of the Army
Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease
$954,097Jay L Rothstein · Immunext, Inc. · R42 · FY2015 · AI
PHYSICAL TELEREHABILITATION IN PATIENTS WITH MULTIPLE SCLEROSIS WITH SIGNIFICANT MOBILITY IMPAIRMENT.
$953,635The Trustees Of Columbia University In The City Of New York · · FY2016 · Department of the Army
Delivery of peptides for inducing voiding associated with neurological retention
$953,265Lesley Marson · Dignify Therapeutics, Llc · R42 · FY2016 · NS
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
$953,224Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2016 · HG
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
$952,967Gary Fanger · Rise Therapeutics, Llc · R44 · FY2025 · AG
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
$952,184David Schlessinger · National Institute On Aging · ZIA · FY2017 · AG
Intracellular Signaling In Endocrine Cells
$950,172Stanko S. Stojilkovic · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$949,519Gary Fanger · Rise Therapeutics, Llc · R44 · FY2020 · DE